Suchergebnisse - "Abou-Alfa, G K"

PubPharm (17)

1

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Sangro, B. | Chan, S. | Kelley, R. | +123

2

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

enthalten in: ESMO open | 2023

von Ducreux, M. | Abou-Alfa, G. | Bekaii-Saab, T. | +28

3

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Abou-Alfa, G. | Qin, S. | Ryoo, B. | +24

4

Interview with Dr Ghassan K Abou-Alfa

enthalten in: Immunotherapy | 2016

von Abou-Alfa, G. | Abou-Alfa, G.

5

CT and MRI of primary and metastatic fibrolamellar carcinoma : a case series of 37 patients

enthalten in: The British journal of radiology | 2014

von Do, R. | McErlean, A. | Ang, C. | +2

6

Randomized phase II study of hepatic arterial embolization of hepatocellular carcinoma (HCC) with micospheres alone (bead block (BB)) versus doxorubicin loaded microspheres (LC bead (LCB))

enthalten in: Journal of vascular and interventional radiology | 2014

von Brown, K. | Gonen, M. | Do, K. | +11

7

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

enthalten in: British journal of cancer | 2013

von Lee, J. | Capanu, M. | O'Reilly, E. | +11

8

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

enthalten in: The British journal of cancer | 2013

von Lee, J. | Capanu, M. | O'Reilly, E. | +11

9

318 Effects of Radiologic Tumor Response of Anti-Glypican-3 GC33 and Multi Tyrosine Kinases Inhibitor Sorafenib in Hepatocellular Carcinoma

enthalten in: The European journal of cancer / A | 2012

von Abou-Alfa, G. | Zhao, B. | Chou, J. | +7

10

328 124I GC33 Positron Emission Tomography (PET), Imaging Biomarker of Glypican-3 in Hepatocellular Carcinoma

enthalten in: The European journal of cancer / A | 2012

von Abou-Alfa, G. | ODonoghue, J. | Gansukh, B. | +7